<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>CLP Blog</provider_name><provider_url>https://clpblog.citizen.org</provider_url><author_name>Paul Levy</author_name><title>Pharma Donors Impede Patient Advocacy Groups from Pressing on High Drug Prices - CLP Blog</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="iMvbtBXsKT"&gt;&lt;a href="https://clpblog.citizen.org/pharma-donors-impede-patient-advocacy-groups-from-pressing-on-high-drug-prices/"&gt;Pharma Donors Impede Patient Advocacy Groups from Pressing on High Drug Prices&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://clpblog.citizen.org/pharma-donors-impede-patient-advocacy-groups-from-pressing-on-high-drug-prices/embed/#?secret=iMvbtBXsKT" width="600" height="338" title="&#x201C;Pharma Donors Impede Patient Advocacy Groups from Pressing on High Drug Prices&#x201D; &#x2014; CLP Blog" data-secret="iMvbtBXsKT" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>by Paul Alan Levy The New York Times carries a story this morning about patient advocacy groups that do not speak out on high drug prices because they are dependent on financial support from the companies that charge those prices. Making me extra grateful for Public Citizen's stringent policy against accepting money from companies.&#xA0;</description></oembed>
